New Product Planning Process Development Case Study
Mid-sized pharmaceutical client had an increase in portfolio size and was seeking to develop a comprehensive process for stage gate decisions and role/responsibilities alignment across global and affiliate teams.
Capturing all necessary activities while generating a succinct and useful resource for planning.
Herspiegel Consulting defined the stage gate decision points, key inputs necessary for decision making and created a comprehensive activity plan with RACI model for all key activities across global and affiliate commercial teams.
The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic ...Read more
Why drug pricing is in the news now and what can be done about it? From Turing Pharmaceuticals to Mylan,...Read more
ACA repeal and replacement complicated by two key challenges...Read more